“…Subsequently, forward or reverse genetic approaches can be employed to identify genes encoding candidate receptors (or other signaling components) for the peptide of interest, either through genetic interaction studies or insensitivity of the receptor mutant to the (synthetic) peptide (4,18,19,27,108,120,133,153,184,209) (Figure 2a) ( Table 1). In the past, available T-DNA insertion lines and functional redundancy were limiting for genetic studies (19), but new approaches, such as CRISPR/Cas9-mediated mutagenesis, are now being employed to overcome this (215). In combination with synthetic or recombinant peptide variants, genetics is a powerful method to identify and characterize peptide-receptor pairs.…”